X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (562) 562
Publication (91) 91
Book / eBook (22) 22
Report (10) 10
Book Review (6) 6
Book Chapter (3) 3
Magazine Article (3) 3
Data Set (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (491) 491
index medicus (424) 424
female (336) 336
male (329) 329
adult (312) 312
hiv infections - drug therapy (309) 309
hiv (308) 308
human immunodeficiency virus--hiv (268) 268
infectious diseases (250) 250
anti-hiv agents - therapeutic use (242) 242
middle aged (241) 241
antiretroviral therapy (223) 223
hiv infection (188) 188
acquired immune deficiency syndrome--aids (182) 182
aids (172) 172
drug therapy (158) 158
risk factors (155) 155
antiretroviral drugs (153) 153
research article (152) 152
antiviral agents (150) 150
health aspects (143) 143
medicine (141) 141
research (137) 137
human immunodeficiency virus (125) 125
analysis (122) 122
acquired immune deficiency syndrome (116) 116
highly active antiretroviral therapy (116) 116
mortality (116) 116
young adult (109) 109
immunology (106) 106
antiretroviral agents (101) 101
patients (101) 101
hiv patients (100) 100
science (100) 100
multidisciplinary sciences (98) 98
therapy (98) 98
hiv infections - epidemiology (97) 97
adolescent (94) 94
care and treatment (93) 93
studies (89) 89
public, environmental & occupational health (86) 86
drugs (84) 84
hiv infections - complications (83) 83
anti-hiv agents - administration & dosage (82) 82
cd4 lymphocyte count (78) 78
treatment outcome (78) 78
anti-hiv agents - adverse effects (77) 77
epidemiology (77) 77
medicine & public health (75) 75
public health (75) 75
cohort studies (72) 72
human-immunodeficiency-virus (71) 71
aged (68) 68
clinical trials (68) 68
infections (68) 68
article (67) 67
data processing (67) 67
medicine and health sciences (66) 66
data collection (65) 65
prevention (65) 65
infection (64) 64
microbiology (64) 64
prevalence (64) 64
risk (64) 64
biology and life sciences (62) 62
protease inhibitors (62) 62
viral load (62) 62
prospective studies (61) 61
medical research (59) 59
viruses (58) 58
adults (57) 57
cd4 antigen (57) 57
complications and side effects (57) 57
adherence (56) 56
retrospective studies (56) 56
dosage and administration (55) 55
hiv infections - virology (55) 55
medication adherence - statistics & numerical data (55) 55
infected patients (54) 54
viral diseases (53) 53
usage (52) 52
active antiretroviral therapy (49) 49
medicine, general & internal (48) 48
pharmacology & pharmacy (48) 48
antiretroviral therapy, highly active (47) 47
pharmacology (47) 47
virology (47) 47
cross-sectional studies (46) 46
virus diseases (46) 46
hiv infections - mortality (45) 45
medical microbiology (45) 45
regression analysis (45) 45
hiv infections - prevention & control (43) 43
tenofovir (43) 43
time factors (43) 43
immunodeficiency viruses (42) 42
preventive medicine (42) 42
cohort (41) 41
health risks (41) 41
microbial pathogens (41) 41
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (16) 16
UofT at Mississauga - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Law (Bora Laskin) - Stacks (2) 2
Online Resources - Online (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Reference (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


HIV medicine, ISSN 1464-2662, 2018, Volume 19, Issue 9, pp. 605 - 618
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 2012, Volume 15, Issue 2, pp. 17426 - n/a
Introduction: HIV-positive patients receiving combination antiretroviral therapy (cART) frequently experience metabolic complications such as dyslipidemia and... 
risk equation | diabetes mellitus | HIV | combination antiretroviral treatment | Risk equation | Combination antiretroviral treatment | Diabetes mellitus | INFECTIOUS DISEASES | GUIDELINES | VALIDATION | ANTIRETROVIRAL THERAPY | MELLITUS | PREVALENCE | IMMUNOLOGY | PROGNOSTIC MODEL | CARDIOVASCULAR-DISEASE | LIPODYSTROPHY | INFECTED PATIENTS | ASSOCIATION | Prognosis | Prospective Studies | Risk Assessment | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Decision Support Techniques | Male | Drug-Related Side Effects and Adverse Reactions - epidemiology | Anti-HIV Agents - administration & dosage | HIV Infections - complications | Adult | Diabetes Mellitus - chemically induced | Female | HIV Infections - drug therapy | Antiretroviral Therapy, Highly Active - methods | Drugs | Antiviral agents | Medical research | Triglycerides | Glucose | HIV (Viruses) | Toy industry | Risk factors | Anti-HIV agents | Dextrose | Complications and side effects | Highly active antiretroviral therapy | Glucose metabolism | Medicine, Experimental | Insulin resistance | Diabetes | Drug therapy | Diabetes therapy | Fasting | Cardiovascular disease | Metabolism | Patients | Cholesterol | Datasets | Studies | Body mass index | Human immunodeficiency virus--HIV | Collaboration | Data collection | Population | Blood pressure | Pharmaceutical industry | Age
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 3/2013, Volume 56, Issue 6, pp. 870 - 879
Journal Article
HIV Medicine, ISSN 1464-2662, 04/2016, Volume 17, Issue 4, pp. 289 - 297
Objectives: The aim of the study was to compare the predictions of five popular cardiovascular disease (CVD) risk prediction models, namely the Data Collection... 
Comparative Study | Atherosclerotic cardiovascular disease risk score (ASCVD) | Systematic coronary risk evaluation (SCORE) | Pharmacology (medical) | Data collection on adverse events of anti-HIV drugs (D:A:D) | Framingham | Cardiovascular disease | Risk prediction | Infectious Diseases | Health Policy | HIV infection | Journal Article | systematic coronary risk evaluation (SCORE) | cardiovascular disease | data collection on adverse events of anti‐HIV drugs (D:A:D) | risk prediction | atherosclerotic cardiovascular disease risk score (ASCVD) | framingham | data collection on adverse events of anti-HIV drugs (D:A:D) | T-CELL COUNT | INFECTIOUS DISEASES | VALIDATION | SOCIETY | PROCAM | WOMEN | RATES | HEART-DISEASE | THERAPY | PROFILE | MEN | Models, Theoretical | Cardiovascular Diseases - etiology | Cross-Sectional Studies | Risk Assessment | United States | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | Young Adult | Netherlands | Adolescent | HIV Infections - complications | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Aged | Drugs | Complications and side effects | Antiviral agents | Risk assessment | HIV (Viruses) | Drug therapy | Coronary heart disease | Risk factors | Anti-HIV agents | Data entry
Journal Article
Journal Article
by Friis-Møller, Nina and Sabin, Caroline A and Weber, Rainer and d'Arminio Monforte, Antonella and El-Sadr, Wafaa M and Reiss, Peter and Thiébaut, Rodolphe and Morfeldt, Linda and De Wit, Stephane and Pradier, Christian and Calvo, Gonzalo and Law, Matthew G and Kirk, Ole and Phillips, Andrew N and Lundgren, Jens D and Bartsch, G and Dabis, F and Houyez, F and Loeliger, E and Tressler, R and Weller, I and Sjøl, A and Sawitz, A and Rickenbach, M and Pezzotti, P and Krum, E and Meester, R and Lavignolle, V and Sundström, A and Poll, B and Fontas, E and Torres, F and Petoumenos, K and Kjær, J and Hammer, S and Neaton, J and Sjøl, A and de Wolf, F and van der Ven, E and Zaheri, S and Van Valkengoed, I and Bronsveld, W and Weigel, H and Brinkman, K and Frissen, P and ten Veen, J and Hillebrand, M and van Dam, P and Schieveld, S and Mulder, J and van Gorp, E and Meenhorst, P and van Eeden, A and Danner, S and Claessen, F and Perenboom, R and Eeftinck Schattenkerk, J.K and Godfried, M and Lange, J and Lowe, S and van der Meer, J and Nellen, F and Pogany, K and van der Poll, T and Prins, J and Ruys, T and van der Valk, M and Wit, F and Richter, C and van Leusen, R and Vriesendorp, R and Jeurissen, F and Kauffmann, R and Koger, E and Bravenboer, B and ten Napel, C and Sprenger, H.G and Law, G and ten Kate, R.W and Leemhuis, M and Kroon, F and Schippers, E and Schrey, G and van der Geest, S and Verbon, A and Koopmans, P and Keuter, M and Telgt, D and van der Ven, A and van der Ende, M and Gyssens, I and de Marie, S and Juttmann, J and van der Heul, C and Schneider, M and Borleffs, J and Hoepelman, I and Jaspers, C and Matute, A and Schurink, C and ...
New England Journal of Medicine, ISSN 0028-4793, 11/2003, Volume 349, Issue 21, pp. 1993 - 2003
Journal Article
Journal of the International Association of Providers of AIDS Care (JIAPAC), ISSN 2325-9574, 3/2014, Volume 13, Issue 2, pp. 153 - 159
Objective: To evaluate the trends in abacavir (ABC) prescription among antiretroviral (ARV) medication-naive individuals following the presentation of the Data... 
abacavir | drug utilization | HIV | pharmacoepidemiology | Myocardial Infarction - epidemiology | Humans | Middle Aged | Risk Factors | Male | Information Dissemination | Practice Patterns, Physicians' - trends | Canada | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Dideoxynucleosides - therapeutic use | Retrospective Studies | Cohort Studies
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 10/2012, Volume 15, Issue 2
INTRODUCTION: HIV-positive patients receiving combination antiretroviral therapy (cART) frequently experience metabolic complications such as dyslipidemia and... 
risk equation | MULTICENTER AIDS COHORT | combination antiretroviral treatment | VALIDATION | ADULTS | diabetes mellitus | ANTIRETROVIRAL THERAPY | MELLITUS | PROGNOSTIC MODEL | HIV | CARDIOVASCULAR-DISEASE | LIPODYSTROPHY | INFECTED PATIENTS | ASSOCIATION
Journal Article
MMW Fortschritte der Medizin, ISSN 1438-3276, 04/2003, Volume 145 Spec No 1, pp. 83 - 83
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 2012, Volume 15, pp. 17426 - 17426
INTRODUCTION: HIV-positive patients receiving combination antiretroviral therapy (cART) frequently experience metabolic complications such as dyslipidemia and... 
Pharmacology | Immunology
Journal Article
HIV medicine, ISSN 1464-2662, 01/2003, Volume 4, Issue 1, pp. 1 - 10
OBJECTIVESTo estimate the 3-year risk of myocardial infarction (MI) among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.... 
Index Medicus
Journal Article